Karl-Heinz Wiesmüller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karl-Heinz Wiesmüller has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Günther Jung
Institute of Organic Chemistry, University of Tuebingen , Tuebingen, Germany
3 shared publicationsArtur J. Ulmer
Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany
2 shared publications- Roland Brock
Dept. of Medical Biochemistry, Arabian Gulf University College of Medicine & Medical Sciences, Manama, Bahrain
2 shared publications - Alan Robert Mackie
School of Food Science and Nutrition, University of Leeds, Leeds LS2 9JT, UK
1 shared publication Andreas Kirchner
Department of Biopharmacy and Pharmaceutic Technology, Saarland University, 66123 Saarbrücken, Germany
1 shared publication- Annette Gabriele Beck‐Sickinger
Institute of Biochemistry Leipzig University Leipzig Germany
1 shared publication
Latest Publications
- Open Access
- 4 November 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (57) , 36116-36124
A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide
Efficient intracellular drug delivery in nanomedicine strongly depends on ways to induce cellular uptake. Conjugation of nanoparticles (NPs) with cell-penetrating peptides (CPPs) is a known means to induce uptake via endocytosis. Here, we functionalized NPs consisting of either poly(D,L-lactide-co-glycolide) (PLGA) or polyethene glycol (PEG)-PLGA block-copolymer with a lactoferrin-derived cell-penetrating peptide (hLF). To enhance the association between the peptide and the polymer NPs, we tested a range of acyl moieties for N-terminal acylation of the peptide as a means to promote noncovalent interactions. Acyl moieties differed in chain length and number of acyl chains. Peptide-functionalized NPs were characterized for nanoparticle size, overall net charge, storage stability, and intracellular uptake. Coating particles with a palmitoylated hLF resulted in minimal precipitation after storage at −20C and homogeneous particle size (<200 nm). Palmitoyl-hLF coated NPs showed enhanced delivery in different cells in comparison to NPs lacking functionalization. Moreover, in comparison to acetyl-hLF, palmitoyl-hLF was also suited for coating and enhancing the cellular uptake of PEG-PLGA NPs.
- 4 November 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (57) , 36116-36124
Open AccessA comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide
Efficient intracellular drug delivery in nanomedicine strongly depends on ways to induce cellular uptake. Conjugation of nanoparticles (NPs) with cell-penetrating peptides (CPPs) is a known means to induce uptake via endocytosis. Here, we functionalized NPs consisting of either poly(D,L-lactide-co-glycolide) (PLGA) or polyethene glycol (PEG)-PLGA block-copolymer with a lactoferrin-derived cell-penetrating peptide (hLF). To enhance the association between the peptide and the polymer NPs, we tested a range of acyl moieties for N-terminal acylation of the peptide as a means to promote noncovalent interactions. Acyl moieties differed in chain length and number of acyl chains. Peptide-functionalized NPs were characterized for nanoparticle size, overall net charge, storage stability, and intracellular uptake. Coating particles with a palmitoylated hLF resulted in minimal precipitation after storage at −20C and homogeneous particle size (<200 nm). Palmitoyl-hLF coated NPs showed enhanced delivery in different cells in comparison to NPs lacking functionalization. Moreover, in comparison to acetyl-hLF, palmitoyl-hLF was also suited for coating and enhancing the cellular uptake of PEG-PLGA NPs.
- Open Access
- 15 February 2005
- Published by Wiley in European Journal of Immunology
- Vol. 35 (3) , 911-921
Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1
Lipoproteins or lipopeptides (LP) are bacterial cell wall components detected by the innate immune system. For LP, it has been shown that TLR2 is the essential receptor in cellular activation. However, molecular mechanisms of LP recognition are not yet clear. We used a FLAG‐labeled derivative of the synthetic lipopeptide N‐palmitoyl‐S‐[2,3‐bis(palmitoyloxy)‐(2R,S)‐propyl]‐(R)‐cysteinyl‐seryl‐(lysyl)3‐lysine (Pam3CSK4) to study the roles of CD14, TLR2 and TLR1 in binding and signaling of LP and their molecular interactions in human cells. The activity of Pam3CSK4‐FLAG was TLR2 dependent, whereas the binding was enabled by CD14, as evaluated by flow cytometry and confocal microscopy. Using FRET and FRAP imaging techniques to study molecular associations, we could show that after Pam3CSK4‐FLAG binding, CD14 and Pam3CSK4‐FLAG associate with TLR2 and TLR1, and TLR2 is targeted to a low‐mobility complex. Thus, LP binding to CD14 is the first step in the LP recognition, inducing physical proximity of CD14 and LP with TLR2/TLR1 and formation of the TLR2 signaling complex.
- 15 February 2005
- Published by Wiley in European Journal of Immunology
- Vol. 35 (3) , 911-921
Open AccessBinding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1
Lipoproteins or lipopeptides (LP) are bacterial cell wall components detected by the innate immune system. For LP, it has been shown that TLR2 is the essential receptor in cellular activation. However, molecular mechanisms of LP recognition are not yet clear. We used a FLAG‐labeled derivative of the synthetic lipopeptide N‐palmitoyl‐S‐[2,3‐bis(palmitoyloxy)‐(2R,S)‐propyl]‐(R)‐cysteinyl‐seryl‐(lysyl)3‐lysine (Pam3CSK4) to study the roles of CD14, TLR2 and TLR1 in binding and signaling of LP and their molecular interactions in human cells. The activity of Pam3CSK4‐FLAG was TLR2 dependent, whereas the binding was enabled by CD14, as evaluated by flow cytometry and confocal microscopy. Using FRET and FRAP imaging techniques to study molecular associations, we could show that after Pam3CSK4‐FLAG binding, CD14 and Pam3CSK4‐FLAG associate with TLR2 and TLR1, and TLR2 is targeted to a low‐mobility complex. Thus, LP binding to CD14 is the first step in the LP recognition, inducing physical proximity of CD14 and LP with TLR2/TLR1 and formation of the TLR2 signaling complex.
- 2 August 2001
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 73 (17) , 4313-4318
Optical Biosensors. Monitoring Studies of Glycopeptide Antibiotic Fermentation Using White Light Interference
This paper describes the design, characterization, and use of an optical biosensor suited for the process control of biotechnological processes. The detector principle is based on reflectometric interference spectroscopy (RIfS). RIfS enables a label-free, product-specific monitoring, with a future outline for on-line process control. The potential of the RIfS biosensor is exemplified by the qualitative and quantitative monitoring of the microbial production of vancomycin-type glycopeptide antibiotics.
- 2 August 2001
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 73 (17) , 4313-4318
Optical Biosensors. Monitoring Studies of Glycopeptide Antibiotic Fermentation Using White Light Interference
This paper describes the design, characterization, and use of an optical biosensor suited for the process control of biotechnological processes. The detector principle is based on reflectometric interference spectroscopy (RIfS). RIfS enables a label-free, product-specific monitoring, with a future outline for on-line process control. The potential of the RIfS biosensor is exemplified by the qualitative and quantitative monitoring of the microbial production of vancomycin-type glycopeptide antibiotics.
- 1 January 1991
- Published by Springer Nature
- p. 202-203
Rapid fully automatic SMPS for epitope mapping of influenza nucleoprotein
- 1 January 1991
- Published by Springer Nature
- p. 202-203
Rapid fully automatic SMPS for epitope mapping of influenza nucleoprotein